共 268 条
[1]
Aggarwal BB(2009)Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe Clin Cancer Res 15 425-430
[2]
Vijayalekshmi RV(2008)Mononuclear cell-derived interleukin-1beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2 Surgery 144 57-65
[3]
Sung B(2002)Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines Cancer Res 62 910-916
[4]
Angst E(1999)Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer Clin Sci (Lond) 96 83-87
[5]
Reber HA(2006)Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival Cancer Immunol Immunother 55 684-698
[6]
Hines OJ(2010)Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 29 317-329
[7]
Eibl G(2010)Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer Clin Cancer Res 16 3028-3034
[8]
Arlt A(2004)Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis Cancer 101 2727-2736
[9]
Vorndamm J(1998)Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 847-850
[10]
Müerköster S(1998)Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines Biochem Biophys Res Commun 157 271-277